Related content

Orexin 2 receptor as a potential target for immunotoxin and antibody-drug conjugate cancer therapy

By                

Oncology Letters, Vol. 3, Iss. 3, 2012-01 ,pp. : 525-529

Spandidos Publications

Access to resources Recommend Favorite

[ 211 At]Methylene Blue for Targeted Radiotherapy of Human Melanoma Xenografts: Dose Fractionation in the Treatment of Cutaneous Tumours

By Link E.M.   Carpenter R.N.   Hansen G.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1240-1247

Elsevier

Access to resources Recommend Favorite

Antibody–drug conjugates for the treatment of B-cell non-Hodgkin’s lymphoma and leukemia

By Chu Yu-Waye   Polson Andrew  

Future Oncology, Vol. 9, Iss. 3, 2013-03 ,pp. : 355-368

Future Medicine

Access to resources Recommend Favorite

Superior therapeutic efficacy of N-l-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drug

By Breistol K.   Hendriks H.R.   Fodstad .  

European Journal of Cancer, Vol. 35, Iss. 7, 1999-07 ,pp. : 1143-1149

Elsevier

Access to resources Recommend Favorite

Human Xenografts, Human Skin and Skin Reconstructs for Studies in Melanoma Development and Progression

By Satyamoorthy K.   Meier F.   Hsu M-Y.   Berking C.   Herlyn M.  

Cancer and Metastasis Reviews, Vol. 18, Iss. 3, 1999-09 ,pp. : 401-405

Springer Publishing Company

Access to resources Recommend Favorite